Non-ischemic neurological manifestations in patients with primary antiphospholipid syndrome

被引:0
作者
Kalashnikova, LA [1 ]
机构
[1] Russian Acad Med Sci, Sci Res Inst Neurol, Moscow, Russia
来源
ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 2005年 / 105卷 / 02期
关键词
antiphospholipid antibodies; primary antiphospholipid syndrome; non-ischemic neurological manifestations;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Ischemic disorders of brain blood circulation caused by brain artery thrombosis due to antiphospholipids-induced anticoagulopathy are main neurological appearances of primary antiphospholipid syndrome (PAPS). A number of neurological disorders in patients with PAPS are the result of primary involvement of the brain and peripheral nervous system. We analyzed the spectrum of neurological non-ischemic PAPS manifestations in 125 patients (102 female, 23 male, mean age - 37.5 +/- 11.3 years) with definite PAPS. These manifestations included headache (67%), epileptic seizures (23%), chorea (15%), optic neuropathy (9%), peripheral neuropathy (6%), multiple sclerosis like syndrome (MSLS) (8%), acute psychosis (2%), myasthenic syndrome (1%), non-vascular parkinsonism (1%). In the development of non-ischemic RAPS manifestations, antiphospholipids as well as other antibodies produced as a result of immune disregulation (antibodies to acetylcholine receptors in myasthenic syndrome, antineuronal antibodies in MSLS) may have pathogenic significance. In some cases a role of infection involved in PAPS manifestation cannot be ruled out.
引用
收藏
页码:18 / 23
页数:6
相关论文
共 50 条
  • [31] Outcome of primary antiphospholipid syndrome in childhood
    Gattorno, M
    Falcini, F
    Ravelli, A
    Zulian, F
    Buoncompagni, A
    Martini, G
    Resti, M
    Picco, P
    Martini, A
    LUPUS, 2003, 12 (06) : 449 - 453
  • [32] RENAL INVOLVEMENT IN PRIMARY ANTIPHOSPHOLIPID SYNDROME
    AMIGO, MC
    GARCIATORRES, R
    ROBLES, M
    BOCHICCHIO, T
    REYES, PA
    JOURNAL OF RHEUMATOLOGY, 1992, 19 (08) : 1181 - 1185
  • [33] Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome
    Nuri, Entela
    Taraborelli, Mara
    Andreoli, Laura
    Tonello, Marta
    Gerosa, Maria
    Calligaro, Antonia
    Argolini, Lorenza Maria
    Kumar, Rajesh
    Pengo, Vittorio
    Meroni, Pier Luigi
    Ruffatti, Amelia
    Tincani, Angela
    IMMUNOLOGIC RESEARCH, 2017, 65 (01) : 17 - 24
  • [34] Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome
    Entela Nuri
    Mara Taraborelli
    Laura Andreoli
    Marta Tonello
    Maria Gerosa
    Antonia Calligaro
    Lorenza Maria Argolini
    Rajesh Kumar
    Vittorio Pengo
    Pier Luigi Meroni
    Amelia Ruffatti
    Angela Tincani
    Immunologic Research, 2017, 65 : 17 - 24
  • [35] 'Non-Criteria' Neurologic Manifestations of Antiphospholipid Syndrome: A Hidden Kingdom to be Discovered
    Islam, Md. Asiful
    Alam, Fahmida
    Kamal, Mohammad Amjad
    Wong, Kah Keng
    Sasongko, Teguh Haryo
    Gan, Siew Hua
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2016, 15 (10) : 1253 - 1265
  • [36] Endothelial function is impaired in patients with primary antiphospholipid syndrome
    Stalc, Monika
    Poredos, Pavel
    Peternel, Polona
    Tomsic, Matija
    Sebestjen, Miran
    Kveder, Tanja
    THROMBOSIS RESEARCH, 2006, 118 (04) : 455 - 461
  • [37] Antiphospholipid Syndrome With a Distinctive Constellation of Neurological Manifestations Blue Toes, Red Valves, White Retinal Spots
    Nokes, Brandon T.
    Dumitrascu, Oana M.
    Shamoun, Fadi E.
    O'Carroll, Cumara B.
    NEUROLOGIST, 2017, 22 (04) : 147 - 149
  • [38] The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study
    Pires da Rosa, Gilberto
    Sousa-Pinto, Bernardo
    Ferreira, Ester
    Araujo, Olga
    Barilaro, Giuseppe
    Bettencourt, Paulo
    Cervera, Ricard
    Espinosa, Gerard
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [39] The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study
    Gilberto Pires da Rosa
    Bernardo Sousa-Pinto
    Ester Ferreira
    Olga Araújo
    Giuseppe Barilaro
    Paulo Bettencourt
    Ricard Cervera
    Gerard Espinosa
    Arthritis Research & Therapy, 24
  • [40] Nephropathy and hypertension as manifestations in a 13-y-old girl with primary antiphospholipid syndrome
    Ohtomo, Y
    Matsubara, T
    Nishizawa, K
    Unno, A
    Motohashi, T
    Yamashiro, Y
    ACTA PAEDIATRICA, 1998, 87 (08) : 903 - 907